Larypront (lysozyme, dequalinium chloride)

Larypront (lysozyme, dequalinium chloride)

SKU:2678
To favorites
Larypront (lysozyme, dequalinium chloride) anti-inflammatory agent for topical use, has an antiviral effect, has an antimicrobial effect against gram-positive and some gram-negative bacteria
Active substance:lysozyme, dequalinium chloride
Pharmacological group:for sore throat
Formulation:Lozenge tablet
Pills in 1 package:20
In stock
$17
11
Description
Features
Reviews

Instructions for Larypront (lysozyme, dequalinium chloride)

English Product Name
Larypront

Release Form
Suction pills

Description Larypront
Suction pills 1 tab
lysozyme hydrochloride 10 mg
dequalinium chloride 250 ug
10 pcs - end-of-line mesh packages (2) - cardboard packs.

ATX codes
R02AA20 Other drugs

Clinical and pharmacological groups / Group affiliation
Topical antiseptic for ENT therapy and dentistry

Active ingredient

  • lysozyme hydrochloride
  • dequalinium chloride

Pharmacotherapeutic group Larypront

Antiseptic agent

Pharmacological effect Larypront

Lysozyme is a natural enzyme known as mucopolysaccharidase. It forms a complex with viruses, preventing them from entering the cells and exhibiting antiviral action. Lysozyme also has antimicrobial properties that are seen in the breakdown of cell walls of gram-positive and some gram-negative bacteria. Lysozyme also blocks histamine, inactivates heparin, and cleaves mucopolysaccharides, giving it an anti-inflammatory, hemostatic, and mucolytic effect.

Dekvalinium chloride is an antiseptic that is effective against gram-positive and gram-negative organisms as well as fungi. The ability of chloride devalinium to reduce surface tension allows the active substances to penetrate deeper layers of the mucous membrane.

Indications Larypront

Against the background of a vital natural process, infectious and inflammatory diseases of the iris of the mouth and all related structures, such as the pharynx and larynx, are in the first place. They include gingivitis, periodontitis, stomatitis (including candidiasis and thrush), pharyngitis, laryngitis, and sore throat. In addition, this group of diseases is associated with the prevention of SARS, as well as causing a sore throat and vocal overload. Importantly, they require special attention before and after oral and pharyngeal surgery, such as dental surgery, operations on the jaws, maxillary sinuses, and tonsils.

Method of use, course and dosage Larypront

For absorption of one dose every two to three hours.

  • Nosology Larypront (ICD codes)
  • B37.0
  • Candida stomatitis
  • J02
  • Acute pharyngitis
  • J03
  • Tonsillitis acute
  • J04.0
  • Acute laryngitis
  • J06.9
  • Acute upper respiratory infection, unspecified
  • J31.2
  • Chronic pharyngitis
  • J35.0
  • Chronic tonsillitis
  • J37.0
  • Chronic laryngitis
  • K05
  • Gingivitis and periodontal diseases
  • K12
  • Stomatitis and allied lesions
  • R07.0
  • Sore throat
  • R49
  • Disturbance in voice
  • Z29.8
  • Other specified preventive measures
  • Z51.4
  • Preparatory procedures for follow-up treatment or examination, not elsewhere classified
Features
Active substance
Pharmacological group
Formulation
Pills in 1 package
Country of origin
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating